May 30, 2024
TOPLINE: A longer duration of diabetes, systemic disease, and use of drugs to reduce blood pressure appear to increase the risk for incident diabetic retinopathy (DR) […]
May 30, 2024
Committee’s Official Designation Pulmonary-Allergy Drugs Advisory Committee Authority The Pulmonary-Allergy Drugs Advisory Committee (the Committee) is established under 15 U.S.C. 1451 et seq.; 21 U.S.C. 321, […]
May 30, 2024
TOPLINE: Black patients with psoriasis are less likely to switch biologic therapies than patients in other racial and ethnic groups, indicating possible differences in treatment patterns. […]
May 29, 2024
A blood test that measures lipoprotein(a) [Lp(a)] has received breakthrough device designation from the US Food and Drug Administration. The Tina-quant Lp(a) RxDx assay, developed by […]
May 29, 2024
Share on PinterestNew research finds that Life’s Essential 8 behaviors may add years to your life by slowing biological aging and reducing your risk of heart […]
May 29, 2024
LYON, FRANCE — High levels of lipoprotein(a) [Lp(a)] in the blood are associated with a significantly increased risk for chronic kidney disease, report investigators who are […]
May 29, 2024
ORA Laboratory Manual Introduction The Laboratory Manual is a reference manual for ORA laboratory personnel and supporting units. It provides personnel with information on internal policies […]
May 29, 2024
Summary Company Announcement Date: May 28, 2024 FDA Publish Date: May 29, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of particulate […]
May 29, 2024
On September 27, 2007, President George W. Bush signed into law H.R. 3580, the Food and Drug Administration Amendments Act of 2007. This new law represents […]